Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.
John J MarianiAmy L MahonySamuel C PodellDaniel J BrooksChristina BrezingSean X LuoNasir H NaqviFrances R LevinPublished in: The American journal on addictions (2021)
The ability to administer a long-acting injection of BXR that assures therapeutic serum levels for a month on the first day of treatment contact is a promising development for the treatment of OUD.